NON SMALL CELL LUNG CANCER METASTATIC
Clinical trials for NON SMALL CELL LUNG CANCER METASTATIC explained in plain language.
Never miss a new study
Get alerted when new NON SMALL CELL LUNG CANCER METASTATIC trials appear
Sign up with your email to follow new studies for NON SMALL CELL LUNG CANCER METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cocktail targets lung cancer in the brain: triple therapy shows promise in early trial
Disease control CompletedThis phase 2 study tested a combination of three drugs in 46 people with a specific type of lung cancer (EGFR-mutated) that had spread to the lining of the brain and spinal cord (meningeal metastasis). The treatment included a high-dose targeted pill (furmonertinib), an intraveno…
Matched conditions: NON SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New combo therapy shows promise for Drug-Resistant lung cancer
Disease control CompletedThis study tested whether adding bevacizumab to osimertinib helps people with advanced non-small cell lung cancer that has a specific genetic change (EGFR and T790M mutations). 155 adults who had already tried other treatments took part. The main goal was to see if the combinatio…
Matched conditions: NON SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE2 • Sponsor: ETOP IBCSG Partners Foundation • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Can zapping cancer spots delay lung cancer progression?
Disease control CompletedThis study tested whether a procedure called local ablative therapy (LAT) can help control metastatic non-small cell lung cancer (NSCLC) when a blood test shows signs of remaining cancer (minimal residual disease, or MRD). 37 patients with stage IV NSCLC received LAT to all visib…
Matched conditions: NON SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Radiation plus pills may slow spread of advanced lung cancer
Disease control CompletedThis study tested adding a precise type of radiation (SBRT) to standard targeted therapy pills for people with stage IV lung cancer that has specific gene changes (EGFR, ALK, or ROS1). The goal was to see if this combination could delay the cancer from spreading to new areas. 27 …
Matched conditions: NON SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New drug cocktails tested for advanced cancers: hope or hype?
Disease control CompletedThis early-phase trial tested several combinations of cancer drugs, including niraparib, TSR-042, bevacizumab, and various chemotherapies, in 60 patients with advanced or metastatic cancer. The main goal was to find safe doses for future studies. The trial has been completed, but…
Matched conditions: NON SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE1 • Sponsor: Tesaro, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Can lung cancer patients safely stop immunotherapy after 6 months?
Disease control CompletedThis phase 3 trial tested whether patients with advanced non-small cell lung cancer (NSCLC) who received initial immunotherapy (nivolumab and ipilimumab) for 6 months could safely stop treatment and be monitored, instead of continuing therapy indefinitely. The study enrolled 265 …
Matched conditions: NON SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE3 • Sponsor: Intergroupe Francophone de Cancerologie Thoracique • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Experimental combo targets Hard-to-Treat lung cancer
Disease control CompletedThis early-phase trial tested a combination of two drugs—nivolumab, a standard immunotherapy, and plinabulin, an experimental drug that attacks tumor blood vessels—in 18 people with advanced non-small cell lung cancer that had worsened after chemotherapy. The main goals were to f…
Matched conditions: NON SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE1 • Sponsor: Lyudmila Bazhenova, M.D. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC